Postoperative Care of the Pancreas-Transplant Recipient

  • Shimul A. Shah
  • Rodney J. Taylor


Diabetes mellitus (DM) affects about 5% of the population and represents the eighth leading cause of death in the United States.1 It is the leading cause of renal failure and blindness in adults and the most frequent, underlying disease leading to amputations.2 Whole-organ pancreas transplantation is no longer an experimental procedure but a valid therapeutic option for patients with type I DM. For patients who are dependent on exogenous insulin for survival, the objectives of pancreas transplantation include insulin independence and normoglycemia, improvement in quality of life, and amelioration of secondary complications of DM.


Human Leukocyte Antigen Mycophenolate Mofetil Pancreas Transplantation Graft Survival Rate Living Donor Kidney Transplant 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Harris MI, Hadden WC, Knowler WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr. Diabetes. 1987;36(4):523–534.PubMedCrossRefGoogle Scholar
  2. 2.
    Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med. 1993;328(23):1676–1685.PubMedCrossRefGoogle Scholar
  3. 3.
    Gruessner AC, Sutherland DE, Gruessner RW. Report of the International Pancreas Transplant Registry. Transplant Proc. 1998;30(2):242–243.PubMedCrossRefGoogle Scholar
  4. 4.
    Sutherland DE, Gruessner RW, Dunn DL, Matas AJ, Humar A, Kandaswamy R, et al. Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg. 2001;233(4):463–501.PubMedCrossRefGoogle Scholar
  5. 5.
    Andreoni KA, Brayman KL, Guidinger MK, Sommers CM, Sung RS. Kidney and pancreas transplantation in the United States, 1996–2005. Am J Transplant. 2007;7(5 Pt 2):1359–1375.PubMedCrossRefGoogle Scholar
  6. 6.
    2006 Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients (OPTN/SRTR) Annual Report., accessed May 2, 2008.
  7. 7.
    Adams MB, Johnson CP, Roza AM. Diabetic complications and the surgeon. Curr Probl Surg. 1996;33(3):223–298.PubMedCrossRefGoogle Scholar
  8. 8.
    Deckert T, Poulsen JE, Larsen M. Prognosis of diabetics with diabetes onset before the age of thirty-one. I. Survival, causes of death, and complications. Diabetologia. 1978;14(6):363–370.PubMedCrossRefGoogle Scholar
  9. 9.
    Troppmann C, Gruessner AC, Benedetti E, Papalois BE, Dunn DL, Najarian JS, et al. Vascular graft thrombosis after pancreatic transplantation: univariate and multivariate operative and nonoperative risk factor analysis. J Am Coll Surg. 1996;182(4):285–316.PubMedGoogle Scholar
  10. 10.
    Gaber AO, Shokouh-Amiri H, Grewal HP, Britt LG. A technique for portal pancreatic transplantation with enteric drainage. Surg Gynecol Obstet. 1993;177(4):417–419.PubMedGoogle Scholar
  11. 11.
    Newell KA, Woodle ES, Millis JM, Piper JB, Huss E, Seaman DS, et al. Pancreas transplantation with portal venous drainage and enteric exocrine drainage offers early advantages without compromising safety or allograft function. Transplant Proc. 1995;27(6):3002–3003.PubMedGoogle Scholar
  12. 12.
    Gaber AO, Shokouh-Amiri MH, Hathaway DK, Hammontree L, Kitabchi AE, Gaber LW, et al. Results of pancreas transplantation with portal venous and enteric drainage. Ann Surg. 1995;221(6):613–622.PubMedCrossRefGoogle Scholar
  13. 13.
    Freise CE, Stock PG, Roberts JP, Melzer JS. Low postoperative wound infection rates are possible following simultaneous pancreas-kidney transplantation. Transplant Proc. 1995;27(6):3069–3070.PubMedGoogle Scholar
  14. 14.
    Kaufman DB, Leventhal JR, Gallon LG, Parker MA, Elliott MD, Gheorghiade M, et al. Technical and immunologic progress in simultaneous pancreas-kidney transplantation. Surgery. 2002;132(4):545–553.PubMedCrossRefGoogle Scholar
  15. 15.
    Starzl TE, Marchioro TL, Porter KA, Iwasaki Y, Cerilli GJ. The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet. 1967;124(2):301–308.PubMedGoogle Scholar
  16. 16.
    Russell PS, Monaco AP. Heterologous antilymphocyte sera and some of their effects. Transplantation 1967; 5(4):Suppl 99.Google Scholar
  17. 17.
    Stratta RJ, Lo A, Shokouh-Amiri M, Egidi MF, Grewal HP, Gaber LW, et al. Improving results in solitary pancreas transplantation with portal-enteric drainage and thymoglobulin induction. Transplant Proc. 2002;34(5):1915–1917.PubMedCrossRefGoogle Scholar
  18. 18.
    Land W, Malaise J, Sandberg J, Langrehr J. Tacrolimus versus cyclosporine in primary simultaneous pancreas-kidney transplantation: preliminary results at 1 year of a large multicenter trial. Transplant Proc. 2002;34(5):1911–1912.PubMedCrossRefGoogle Scholar
  19. 19.
    Magliocca JF, Knechtle SJ. The evolving role of alemtuzumab (Campath-1H) for immunosuppressive therapy in organ transplantation. Transpl Int. 2006;19(9):705–714.PubMedCrossRefGoogle Scholar
  20. 20.
    Bindi ML, Biancofiore G, Meacci L, Bellissima G, Nardi S, Pieri M, et al. Early morbidity after pancreas transplantation. Transpl Int. 2005;18(12):1356–1360.PubMedCrossRefGoogle Scholar
  21. 21.
    Stratta RJ, Taylor RJ, Ozaki CF, Bynon JS, Langnas AN, Shaw BW Jr. Combined pancreas-kidney transplantation versus kidney transplantation alone: analysis of benefit and risk. Transplant Proc. 1993;25(1 Pt 2):1298–1301.PubMedGoogle Scholar
  22. 22.
    Halpern H, Miyoshi E, Kataoka LM, Fo RA, Miranda SB, Marumo CK, et al. Glycemic control during pancreas transplantation: continuous infusion versus bolus. Transplant Proc. 2004;36(4):984–985.PubMedCrossRefGoogle Scholar
  23. 23.
    Bindi ML, Biancofiore G, Pasquini C, Lugli D, Amorese G, Bellissima G, et al. Pancreas transplantation: problems and prospects in intensive care units. Minerva Anestesiol. 2005;71(5):207–221.PubMedGoogle Scholar
  24. 24.
    Harper SJ, Moorhouse J, Abrams K, Jurewicz A, Nicholson M, Horsburgh T, et al. The beneficial effects of oral nifedipine on cyclosporin-treated renal transplant recipients – a randomised prospective study. Transpl Int. 1996;9(2):115–125.PubMedCrossRefGoogle Scholar
  25. 25.
    Halpern H, Miyoshi E, Kataoka LM, Khouri Fo RA, Miranda SB, Marumo CK, et al. Anesthesia for pancreas transplantation alone or simultaneous with kidney. Transplant Proc. 2004;36(10):3105–3106.PubMedCrossRefGoogle Scholar
  26. 26.
    Stratta RJ, Taylor RJ, Ozaki CF, Bynon JS, Miller SA, Knight TF, et al. A comparative analysis of results and morbidity in type I diabetics undergoing preemptive versus postdialysis combined pancreas-kidney transplantation. Transplantation. 1993;55(5):1097–1103.PubMedCrossRefGoogle Scholar
  27. 27.
    Ozaki CF, Stratta RJ, Taylor RJ, Langnas AN, Bynon JS, Shaw BW Jr. Surgical complications in solitary pancreas and combined pancreas-kidney transplantations. Am J Surg. 1992;164(5):546–551.PubMedCrossRefGoogle Scholar
  28. 28.
    Stratta RJ, Taylor RJ, Bynon JS, Lowell JA, Sindhi R, Wahl TO. Surgical treatment of diabetes mellitus with pancreas transplantation. Ann Surg. 1994;220(6):809–817.PubMedCrossRefGoogle Scholar
  29. 29.
    Humar A, Kandaswamy R, Granger D, Gruessner RW, Gruessner AC, Sutherland DE. Decreased surgical risks of pancreas transplantation in the modern era. Ann Surg. 2000;231(2):269–275.PubMedCrossRefGoogle Scholar
  30. 30.
    Benedetti E, Troppmann C, Gruessner AC, Sutherland DE, Dunn DL, Gruessner WG. Pancreas graft loss caused by intra-abdominal infection. A risk factor for a subsequent pancreas retransplantation. Arch Surg. 1996;131(10):1054–1060.PubMedCrossRefGoogle Scholar
  31. 31.
    Benedetti E, Gruessner AC, Troppmann C, et al. Intra-abdominal fungal infections after pancreatic transplantation: incidence, treatment, and outcome. J Am Coll Surg. 1996;183(4):307–316.PubMedGoogle Scholar
  32. 32.
    Papalois BE, Troppmann C, Gruessner AC, et al. Long-term peritoneal dialysis before transplantation and intra-abdominal infection after simultaneous pancreas-kidney transplantations. Arch Surg. 1996;131(7):761–766.PubMedCrossRefGoogle Scholar
  33. 33.
    Freise CE, Narumi S, Stock PG, Melzer JS. Simultaneous pancreas-kidney transplantation: an overview of indications, complications, and outcomes. West J Med. 1999;170(1):11–18.PubMedGoogle Scholar
  34. 34.
    Sollinger HW, Messing EM, Eckhoff DE, et al. Urological complications in 210 consecutive simultaneous pancreas-kidney transplants with bladder drainage. Ann Surg. 1993;218(4):561–568.PubMedCrossRefGoogle Scholar
  35. 35.
    Connolly EM, Baktavatsalam R, O’Malley K, Little DM, Hickey DP. Enteric conversion after bladder-drained pancreatic transplantation; a simple and safe salvage procedure. Eur J Surg. 2001;167(5):371–374.PubMedCrossRefGoogle Scholar
  36. 36.
    Stratta RJ, Sindhi R, Sudan D, Jerius JT, Radio SJ. Duodenal segment complications in vascularized pancreas transplantation. J Gastrointest Surg. 1997;1(6):534–544.PubMedCrossRefGoogle Scholar
  37. 37.
    West M, Gruessner AC, Metrakos P, Sutherland DE, Gruessner RW. Conversion from bladder to enteric drainage after pancreaticoduodenal transplantations. Surgery. 1998;124(5):883–893.PubMedCrossRefGoogle Scholar
  38. 38.
    Kuo PC, Johnson LB, Schweitzer EJ, Bartlett ST. Simultaneous pancreas/kidney transplantation – a comparison of enteric and bladder drainage of exocrine pancreatic secretions. Transplantation. 1997;63(2):238–243.PubMedCrossRefGoogle Scholar
  39. 39.
    Dunn DL, Gillingham KJ, Kramer MA, et al. A prospective randomized study of acyclovir versus ganciclovir plus human immune globulin prophylaxis of cytomegalovirus infection after solid organ transplantation. Transplantation. 1994;57(6):876–884.PubMedCrossRefGoogle Scholar
  40. 40.
    Humar A, Mazzulli T, Moussa G, et al. Clinical utility of cytomegalovirus (CMV) serology testing in high-risk CMV D+/R- transplant recipients. Am J Transplant. 2005;5(5):1065–1070.PubMedCrossRefGoogle Scholar
  41. 41.
    Paraskevas S, Coad JE, Gruessner A, et al. Posttransplant lymphoproliferative disorder in pancreas transplantation: a single-center experience. Transplantation. 2005;80(5):613–622.PubMedCrossRefGoogle Scholar
  42. 42.
    Martinenghi S, Dell’Antonio G, Secchi A, Di Carlo V, Pozza G. Cancer arising after pancreas and/or kidney transplantation in a series of 99 diabetic patients. Diabetes Care. 1997;20(3):272–275.PubMedCrossRefGoogle Scholar
  43. 43.
    Radio SJ, Stratta RJ, Taylor RJ, Linder J. The utility of urine cytology in the diagnosis of allograft rejection after combined pancreas-kidney transplantation. Transplantation. 1993;55(3):509–516.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Shimul A. Shah
    • 1
  • Rodney J. Taylor
    • 2
  1. 1.Department of SurgeryUniversity of Massachusetts Medical SchoolWorcesterUSA
  2. 2.Department of SurgeryUniversity of Massachusetts Medical SchoolWorcesterUSA

Personalised recommendations